GBUK Group

Explore the most recent news and cutting-edge innovations in medical devices from GBUK Group staying informed about their latest developments and advancements in the field of medical devices.

  • admin
  • No Comments

Christmas & New Year Ordering and Opening Times
Christmas & New Year Ordering and Opening Times 344 344 admin

Ordering & Opening Times

Christmas & New Year Ordering and Opening Times: Find out when our offices are open over the festive period, the times orders can be placed, and the delivery schedules during this time. read more

GBUK Group Icon
  • admin
  • No Comments

GBUK Group acquires Severn Healthcare Technologies
GBUK Group acquires Severn Healthcare Technologies 344 344 admin

GBUK Group, a portfolio company of A&M Capital Europe (“AMCE”), a London-based private equity firm with €650 million of commitments under management, has acquired UK-based Severn Healthcare Technologies (“Severn”), a value-added and fast-growing distributor of single-use medical devices.

Founded in 2014, Severn specialises in providing next-generation single-use medical devices across the Ear, Nose, and Throat (“ENT”) and Neuro-Otology clinical specialisms. Supporting the adoption of clinical innovation in operating theatres across the National Health Service (“NHS”) and the UK Private market, we believe Severn has built a reputation as a trusted partner to surgical clinicians on the foundations of deep technical expertise and exceeding customer service.

The acquisition of Severn represents GBUK’s second acquisition since AMCE’s investment in December 2023. The acquisition is expected to strengthen GBUK’s clinical specialist positioning further while expanding its product presence in two new and innovative therapeutic areas.

GBUK were advised by Rothschild & Co as financial adviser, Burness Paull as legal adviser, Accuracy as accounting adviser, and PMSI as commercial adviser.

About GBUK Group

Headquartered in the United Kingdom, GBUK Group designs develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK Group has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinged on wrap-around services. To find out more, visit www.gbukgroup.com.

About A&M Capital Europe

AMCE is a London-headquartered private equity investment firm specialising in building pan-European platform companies through buy-and-build and organic growth initiatives. AMCE Fund I currently has €650 million of commitments under management, and Severn represents AMCE’s twenty-third transaction across its eight portfolio companies. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm that manages commitments totalling ~€5.5 billion across all its investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest growth and operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.

GBUK Group Icon
  • admin
  • No Comments

GBUK Acquires Care & Independence
GBUK Acquires Care & Independence 344 344 admin

GBUK, a portfolio company of A&M Capital Europe (“AMCE”), a London-based private equity firm with €650 million of commitments under management, has acquired Care & Independence (“C&I”), a fast-growing UK provider of patient handling and moving devices.

Founded in 1985, C&I specialises in the provision of medical slings, bathing equipment and broader postural support devices. Within its core UK market, C&I is a preferred supplier to the National Health Service (“NHS”) and primarily serves the needs of patients within the community setting via loan store operators, independent local authorities, and NHS Trusts. Like GBUK, C&I operates a clinician-orientated high-touch sales model that supports Occupational Therapists with clinical product training and patient requirement assessments.

The acquisition of C&I represents GBUK’s first acquisition since AMCE’s investment in December 2023. The acquisition is expected to strengthen GBUK’s positioning within the UK patient handling market, providing further breadth to GBUK’s product offering and an established platform for growth within the community-setting.

AMCE and GBUK were advised by Burness Paull as legal adviser, Accuracy as accounting adviser, and EY as tax adviser.

About GBUK

Headquartered in the United Kingdom, GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging on wrap-around services.

About A&M Capital Europe

AMCE is a London-headquartered private equity investment firm specialising in building pan-European platform companies through buy-and-build and organic growth initiatives. AMCE Fund I currently has €650 million of commitments under management, and C&I represents AMCE’s twenty-second transaction. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm that manages funds and accounts with commitments totalling ~€5.5 billion across four investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest growth and operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.

GBUK Group Icon

Elevating Patient Evacuations: A Pinnacle Journey with Advanced Techniques
Elevating Patient Evacuations: A Pinnacle Journey with Advanced Techniques 344 344 marketing

In the field of patient care, prioritising a graceful and dignified evacuation process stands as a fundamental necessity.

Our team are dedicated to ensuring the well-being, safety, and dignity of our patients, employs state-of-the-art techniques and specialised equipment to orchestrate a seamless transition. Join us on this transformative journey as we shine a spotlight on innovative tools, such as the FloJac, Banana Slide Sheets, and Lateral Boards, that redefine the evacuation experience.

A Pioneering Approach to Risk Assessment: Every successful evacuation commences with an exhaustive risk assessment. Our team meticulously scrutinises potential challenges, tailoring the evacuation plan to suit the unique needs of each patient. This meticulous initial step lays the groundwork for a carefully coordinated and efficient process.

Cutting-Edge Techniques Unveiled: Taking centre stage in our evacuation procedures is the revolutionary FloJac—a device that redefines patient care. Its innovative design facilitates gentle and controlled movement, minimising discomfort and ensuring the utmost safety. This advanced technology transforms the evacuation experience, delivering a profound impact on both patients and caregivers alike.

Banana Slide Sheets: Redefining Comfort and Control: Our commitment to patient comfort is exemplified by the utilisation of Banana Slide Sheets. Specifically crafted, these sheets facilitate smooth and controlled movements, effectively reducing friction and enhancing the overall evacuation process. Playing a pivotal role in preserving dignity, Banana Slide Sheets ensure a positive experience for patients with diverse needs.

Lateral Boards for Precision Transitions: Precision is paramount during evacuations, and lateral boards emerge as indispensable tools for achieving seamless transitions. These boards assist in moving patients with care and accuracy, addressing the unique challenges presented by various evacuation scenarios. The proficiency of our team in utilising lateral boards guarantees that each patient undergoes a dignified and secure evacuation.

Patient-Centric Excellence: Throughout the evacuation process, our unwavering focus on the patient remains resolute. The use of specialised equipment aligns seamlessly with our commitment to providing personalised and compassionate care. Every action is guided by the principles of dignity, ensuring that each patient feels profoundly valued and supported during the entire evacuation journey.

From the systematic risk assessment to the final steps of a patient’s evacuation, our dedicated team employs cutting-edge techniques and specialised equipment to redefine the entire experience. The use of the FloJac, Banana Slide Sheets, and Lateral Boards underscores our unwavering commitment to ensuring patient comfort, safety, and dignity. As we navigate the intricacies of evacuations, the overarching goal remains crystal clear: to provide a seamless and dignified experience for every patient.

GBUK Group Icon
  • admin
  • No Comments

A&M Capital Europe Announces Majority Investment in GBUK Group
A&M Capital Europe Announces Majority Investment in GBUK Group 344 344 admin

A&M Capital Europe Announces Majority Investment in GBUK Group

January 9, 2024 – A&M Capital Europe (“AMCE”), a London-based middle-market private equity investment firm with €650 million of assets under management, announces the acquisition of a majority stake in GBUK Group (the “Company”), a leading global provider of specialist single-use medical devices, from H2 Equity Partners (“H2EP”).

Headquartered in the United Kingdom, GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK National Health Service (“NHS”) and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging on wrap-around services.

The partnership with AMCE is expected to enable GBUK to enhance patient care further and drive the innovation required to support the evolving needs of patients and healthcare providers. Leveraging GBUK’s intimate understanding of patient needs, new product development expertise and global supply-chain capabilities, the Company is well-positioned to continue delivering on this mission and support patients globally.

Additionally, with AMCE’s support, GBUK intends to pursue bolt-on acquisitions, focusing primarily on proprietary medical device specialists in the United Kingdom and broader European and North American markets.

GBUK will continue under the leadership of its existing management team, led by CEO Mike Geering, with Mike and his team investing alongside AMCE.

AMCE was advised by Weil, Gotshal & Manges as legal adviser, Houlihan Lokey as financial adviser, MDW Capital Partners as debt adviser, Boston Consulting Group as commercial adviser, Alvarez & Marsal as accounting and operational adviser, and EY as tax adviser.

About A&M Capital Europe

AMCE is a London-headquartered, middle-market private equity investment firm specialising in building pan-European platform companies through buy-and-build in the middle market. AMCE Fund I currently has €650 million of assets under management, and GBUK represents AMCE’s seventeenth transaction. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm with ~€4.8 billion in assets under management across four investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.

Search Information on GBUK